Literature DB >> 7952391

Primary gastric lymphomas: a clinicopathologic study with literature review.

D H Roukos1, C Hottenrott, A Encke, G Baltogiannis, D Casioumis.   

Abstract

Prognostic factors and treatment results were analysed in 28 consecutive patients with primary gastric lymphoma (PGL) diagnosed and treated, all by surgery and in many cases with additional chemotherapy (CT) and/or radiotherapy (RT), between 1977 and 1988. There were 13 patients in stage IE, 5 in IIE, and 10 in stage IV. The resection rate was 96.4% (27/28). Sixteen patients underwent an extended total and 11 a subtotal gastrectomy. Seventeen out of 25 cases (68%) were diagnosed by endoscopic biopsies. In 10 endoscopically diagnosed PGL cases the clinical staging and separation between stages IE and IIE from stage IV, due to ultrasonographic scan, computed tomography and bone marrow biopsy, was correct and the same with the surgical-pathological staging information. According to the Kiel-classification 18 patients had a low-grade and 9 patients a high-grade lymphoma. One patient could not be classified. All patients were completely followed-up, in an average time of 52 months. The probability of overall 5-year survival was 92% in stage IE, 75% in stage IIE, 88% in stages IE+IIE together, and 35% in stage IV. Extent of surgery (total vs. subtotal gastrectomy), Kiel-classification (low-grade vs. high-grade malignant histologic subtypes) and adjuvant CT in patients with stage IE (all 11 patients without CT remain in complete remission after an average of 45 months) did not significantly influence survival. The sole prognostic factor with proven impact on survival was the stage of disease (IE+IIE vs. IV: P = 0.001). For the Kiel-classification in particular there was no significant difference between low-grade and high-grade lymphomas with regard to the sex, symptomatic, extent of surgery, and stage at operation. These findings, together with data from the literature, suggest that gastric resection seems to be the optimal primary treatment in clinically assessed stages IE or IIE. In patients with stage IE disease, surgical resection can result in a cure, with no need for further therapy. The CT and/or RT can be effective in unresected and even bulky cases. Because of the difference in primary treatment, a preoperative clinical staging and separation between early stages from stage IV is always indicated.

Entities:  

Mesh:

Year:  1994        PMID: 7952391     DOI: 10.1016/0960-7404(94)90007-8

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  36 in total

1.  Laparoscopic sphincter-preserving rectal cancer surgery: a highly demanding procedure.

Authors:  Christos G Katsios; Georgios Baltogiannis
Journal:  Surg Endosc       Date:  2010-12       Impact factor: 4.584

2.  High-quality clinical practice: laparoscopic rectal cancer resection.

Authors:  Georgios Baltogiannis; Christos Katsios
Journal:  Surg Endosc       Date:  2010-11       Impact factor: 4.584

3.  Sparing minilaparotomy in robotic low anterior resection for cancer.

Authors:  Christof Hottenrott; Christos Katsios
Journal:  Surg Endosc       Date:  2010-11       Impact factor: 4.584

4.  Endoscopic submucosal dissection for remnant gastric cancer.

Authors:  Georgios Baltogiannis; Christos Katsios
Journal:  Surg Endosc       Date:  2010-12       Impact factor: 4.584

5.  Comparative-effectiveness research and good clinical practice for laparoscopic rectal surgery after neoadjuvant treatment.

Authors:  C Hottenrott
Journal:  Surg Endosc       Date:  2011-01       Impact factor: 4.584

6.  To the editor: the role of prophylactic surgery in cancer prevention.

Authors:  Michael Fatouros; Georgios Baltogiannis
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

7.  Robotic surgery for rectal cancer: may it improve also survival?

Authors:  Dimosthenis Ziogas; Dimitrios Roukos
Journal:  Surg Endosc       Date:  2008-03-05       Impact factor: 4.584

8.  EGFR as a Prognostic Marker for Gastric Cancer.

Authors:  Theodore Liakakos; Nikolaos Xeropotamos; Dimosthenis Ziogas; Dimitrios Roukos
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

9.  Laparoscopic gastrectomy for organ-confined cancer: a reality in the West?

Authors:  Ernst Hanisch; Dimosthenis Ziogas
Journal:  Surg Endosc       Date:  2009-05-15       Impact factor: 4.584

10.  Impact of laparoscopic D2 gastrectomy on long-term survival for early gastric cancer.

Authors:  Dimitrios Kanellos; Ioannis Kanellos
Journal:  Surg Endosc       Date:  2009-05-16       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.